Related content

Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study

By Blouin J.   Dragomir A.   Fredette M.   Ste-Marie L.-G.   Fernandes J.   Perreault S.  

Osteoporosis International, Vol. 20, Iss. 9, 2009-09 ,pp. : 1571-1581

Springer Publishing Company

Access to resources Recommend Favorite

Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in the Netherlands*

By Van der Linden Michiel W.   Gaugris Sabine   Kuipers Ernst J.   Van den Bemt Bart J. F.   van Herk-Sukel Myrthe P. P.   Herings Ron M. C.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 195-204

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis

By Iwamoto Jun   Takeda Tsuyoshi   Sato Yoshihiro  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 919-928

Informa Healthcare

Access to resources Recommend Favorite

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women

By Ringe J. D.   Christodoulakos G. E.   Mellström D.   Petto H.   Nickelsen T.   Marín F.   Pavo I.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2677-2687

Informa Healthcare

Access to resources Recommend Favorite

Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 5, 2015-05 ,pp. : 298-304

John Wiley & Sons Inc

Access to resources Recommend Favorite